GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Shiller PE Ratio

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Shiller PE Ratio : 36.65 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Shiller PE Ratio?

As of today (2024-04-27), Cipher Pharmaceuticals's current share price is $6.23. Cipher Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 was $0.17. Cipher Pharmaceuticals's Shiller PE Ratio for today is 36.65.

The historical rank and industry rank for Cipher Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

CPHRF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.67   Med: 29.75   Max: 464
Current: 38.94

During the past years, Cipher Pharmaceuticals's highest Shiller PE Ratio was 464.00. The lowest was 13.67. And the median was 29.75.

CPHRF's Shiller PE Ratio is ranked worse than
72.73% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs CPHRF: 38.94

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.300. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.17 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cipher Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Cipher Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Shiller PE Ratio Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.33 18.21 17.49 16.62 24.87

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.62 13.72 14.62 15.98 24.87

Competitive Comparison of Cipher Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Shiller PE Ratio falls into.



Cipher Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cipher Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.23/0.17
=36.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Cipher Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.3/125.4675*125.4675
=0.300

Current CPI (Dec. 2023) = 125.4675.

Cipher Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.136 98.604 0.173
201406 0.160 99.473 0.202
201409 0.300 99.394 0.379
201412 0.081 98.367 0.103
201503 0.090 99.789 0.113
201506 -0.020 100.500 -0.025
201509 -0.090 100.421 -0.112
201512 0.080 99.947 0.100
201603 -0.100 101.054 -0.124
201606 -0.130 102.002 -0.160
201609 -0.810 101.765 -0.999
201612 -0.430 101.449 -0.532
201703 -0.130 102.634 -0.159
201706 0.040 103.029 0.049
201709 0.100 103.345 0.121
201712 0.140 103.345 0.170
201803 -0.050 105.004 -0.060
201806 0.080 105.557 0.095
201809 0.030 105.636 0.036
201812 -0.040 105.399 -0.048
201903 0.030 106.979 0.035
201906 0.050 107.690 0.058
201909 -0.080 107.611 -0.093
201912 0.110 107.769 0.128
202003 0.100 107.927 0.116
202006 0.020 108.401 0.023
202009 0.060 108.164 0.070
202012 -0.010 108.559 -0.012
202103 0.050 110.298 0.057
202106 0.100 111.720 0.112
202109 0.030 112.905 0.033
202112 0.100 113.774 0.110
202203 0.080 117.646 0.085
202206 0.080 120.806 0.083
202209 0.100 120.648 0.104
202212 0.760 120.964 0.788
202303 0.100 122.702 0.102
202306 0.120 124.203 0.121
202309 0.270 125.230 0.271
202312 0.300 125.468 0.300

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cipher Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines

From GuruFocus